Recombinant Technologies LLC
Recombinant Technologies LLC, established in 1999, is a biotechnology company based in Cheshire, CT, focused on developing innovative therapeutics for neurodegenerative diseases, particularly Alzheimer's. With significant investment in their flagship therapeutic, AmyTrap, the company aims to address the unmet medical needs of patients suffering from beta-amyloidopathy diseases.
Their mission emphasizes the alleviation of symptoms without causing pain and suffering, aiming to enhance the quality of life for patients. Through the development of proof-of-concept tested and pre-clinically validated beta-amyloid capturing molecules, Recombinant Technologies envisions a meaningful clinical impact on various neurodegenerative conditions.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.